Committee advances public-health measures: MOU for one-stop services, grant application and support for HIV screening bill

The Government Operations Committee on May 19 approved several public-health items intended to respond to a recent local HIV outbreak: acceptance of recurring Maine Department of Health and Human Services prevention funds, an MOU with Wabanaki Public Health and Wellness to advance a one-stop shop for testing and services, and a joint application to Gilead Sciences for $70,000 to cover start-up costs of the pilot. Committee members also indicated support for LD 1970, a state bill to make HIV screening part of general consent in health-care settings.

Public Health Director Jen Gunnarsson told the committee the DHHS funds cover ongoing work in substance-use disorder prevention, tobacco control, and healthy-eating/active-living initiatives. On the MOU with Wabanaki, Gunnarsson said the one-stop shop model would consolidate services at Wabanaki’s Hancock Street location and offer "HIV, hepatitis C, and other STI testing with our new handy dandy machine that gives results in an hour," along with vaccines, a telehealth room and space for street outreach partners and city outreach staff.

Gunnarsson emphasized the collaboration was contingent on securing funding for rent, supplies and part-time staffing. She estimated annual operating costs (excluding start-up expenses) could run "close to about... a hundred grand a year" for rent, supplies and base staff time. To cover start-up costs, the city will co-apply with Wabanaki for a $70,000 Gilead grant to support a one-year pilot; Gunnarsson described funding as competitive in the current environment.

The committee approved acceptance of the Maine DHHS funding and the MOU on consent; motions to proceed with the Gilead application were moved and seconded and recorded as passed without objection. Director Kinnamon briefed the committee on LD 1970, saying the bill would make HIV screening routine (opt-out) rather than requiring separate consent and that evidence shows opt-out screening increases testing and reduces stigma. Committee members indicated informal support for the bill.

All the approvals at committee are contingent on final funding, contractual details and any required partner agreements; the MOU and grant application do not in themselves create new city-funded services until funding is secured.